A fault in J&J MedTech’s CEREPAK detachable coils, used in intracranial aneurysm embolisation procedures, has been associated ...

Acquisitions and spinoffs in 2025 surpassed the previous three years, according to a report from Bain & Company.

Investing in stocks inevitably means buying into some companies that perform poorly. But the last three years have ...

The FDA has flagged J&J Medtech’s recall of its Cerepak detachable coils as Class I in the wake of one death and four serious ...

Medtech startups struggle with funding as strategic buyers consolidate, preferring fully developed products over early ...

Discover how global tariffs are driving changes in medtech growth strategies, M&A activities, and manufacturing footprints.

Johnson & Johnson MedTech (NYSE:JNJ) today announced 12-month pilot data from a study of its investigational Omnypulse ...

Argá Medtech today announced positive findings from a first-in-human study of its Coherent Sine-Burst Electroporation (CSE) system.

Biolinq CEO Richard Yang highlights smart patch’s potential to track multiple biomarkers within a single system.

While in 2025 med-tech financings averaged $3.3 billion per month, January 2026 saw the sector bring in $1.52 billion across 39 transactions. It was the lowest monthly total since November 2024’s $924 ...

Aztron Medtech, a privately held orthopedic device company, today announced that more than 100 clinical procedures have now ...

India is witnessing a surge in MedTech startups, yet many are playing it safe by focusing on low-risk innovations. Experts call for bold, high-tech investments to drive disruption in the medtech field ...